Back to results
US 2024/0189292 A1Published application
Substituted pyridine-2,4-dione derivatives
AssigneeMedshine Discovery Inc.
InventorsXiaobing YAN, Wei LAI, Charles Z. DING, Shuhui CHEN
Life of this patent
Estimating the term…
Abstract
The present invention relates to a series of substituted pyridine-2,4-dione derivatives and preparation methods therefor, and in particular, to a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.
Claims21
1-22. (canceled)
A compound of formula (I) or a pharmaceutically acceptable salt thereof,
- wherein
- R1 and R2 are each independently selected from H, F, Cl, Br, I, —OH, —NH2, —CN, C1-4 alkyl, and C1-4 alkoxy, wherein the C1-4 alkyl and C1-4 alkoxy are each independently and optionally substituted by 1, 2, or 3 Ra;
- alternatively, R1 and R2 together with the carbon atom to which they are attached form a C3-6 cycloalkyl ring or a 3- to 6-membered heterocycloalkyl ring, wherein the C3-6 cycloalkyl ring and the 3- to 6-membered heterocycloalkyl ring are each independently and optionally substituted by 1, 2, 3, or 4 Rb;
- R3 is selected from H and F;
- R4 is selected from H, C1-4 alkyl, and C3-4 cycloalkyl, wherein the C1-4 alkyl and C3-4 cycloalkyl are each independently and optionally substituted by 1, 2, or 3 Rc;
- R5 is selected from H and C1-4 alkyl;
- each R6 is independently selected from H, F, Cl, Br, I, —OH, —NH2, —CN, C1-4 alkyl, and C1-4 alkoxy, wherein the C1-4 alkyl and C1-4 alkoxy are each independently and optionally substituted by 1, 2, or 3 Rd;
- each Ra is independently selected from F, Cl, Br, I, —OH, —NH2, —CN, C1-4 alkyl, C1-4 alkoxy, —CORa1, —CO2Ra1, —SO2Ra1, —SO2NRa1Ra2, and —CONRa1Ra2, wherein the C1-4 alkyl and C1- alkoxy are each independently and optionally substituted by 1, 2, or 3 R;
- Ra1 and Ra2 are each independently selected from H and C1-4 alkyl;
- alternatively, Ra1 and Ra2 together with the nitrogen atom to which they are attached form a 4- to 6-membered heterocycloalkyl ring, wherein the 4- to 6-membered heterocycloalkyl ring is independently and optionally substituted by 1, 2, 3, or 4 Re;
- each Rb is independently selected from F, Cl, Br, I, —OH, —NH2, —CN, C1-4 alkyl, C1-4 alkoxy, —CORb1, —CO2Rb1, —SO2Rb1, —SO2NRb1Rb2, and —CONRb1Rb2, wherein the C1-4 alkyl and the C1-4 alkoxy are each independently and optionally substituted by 1, 2, or 3 R;
- Rb1 and Rb2 are each independently selected from H and C1-4 alkyl;
- alternatively, Rb1 and Rb2 together with the nitrogen atom to which they are attached form a 4- to 6-membered heterocycloalkyl ring, wherein the 4- to 6-membered heterocycloalkyl ring is independently and optionally substituted by 1, 2, 3, or 4 Rf;
- each Rc is independently selected from F, Cl, Br, I, —OH, —NH2, —CN, C1-4 alkyl, and C1-4 alkoxy;
- each Rd is independently selected from F, Cl, Br, I, —OH, —NH2, —CN, C1-4 alkyl, and C1-4 alkoxy;
- each Re is independently selected from F, Cl, Br, I, —OH, —NH2, —CN, C1-4 alkyl, and C1-4 alkoxy;
- each Rf is independently selected from F, Cl, Br, I, —OH, —NH2, —CN, C1-4 alkyl, and C1-4 alkoxy;
- each R is independently selected from F, Cl, Br, I, —OH, —NH2, and —CN;
- n is selected from 1, 2, 3, or 4;
- the 3- to 6-membered heterocycloalkyl ring and the 4- to 6-membered heterocycloalkyl ring each independently comprise 1, 2, 3, or 4 atoms or atomic groups each independently selected from N, O, S, and NH.
17 more elements
A compound of the following formula or a pharmaceutically acceptable salt thereof, selected from and .
A compound of the following formula or a pharmaceutically acceptable salt thereof, selected from
Dependencies are inferred from the claim text.